Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.

Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, Sinclair LK, Foeller C, Chow EP, Browing JL, Ramachandran KL, et al.

Nature. 1986 Mar 6-12;320(6057):77-81.

PMID:
2936963
2.

Lipocortin and vasocortin: two species of anti-inflammatory proteins mimicking the effects of glucocorticoids.

Sautebin L, Carnuccio R, Ialenti A, Di Rosa M.

Pharmacol Res. 1992 Jan;25(1):1-12. Review.

PMID:
1371190
3.

[Lipocortin--a Ca2+-binding protein which has anti-phospholipase A2 activity].

Tokuda M, Waisman DM, Hatase O.

Seikagaku. 1988 Jan;60(1):26-31. Review. Japanese. No abstract available.

PMID:
2969024
4.

Phospholipase A2 and lipocortin effects.

Dennis EA, Davidson FF.

Prog Clin Biol Res. 1990;349:47-54. Review. No abstract available.

PMID:
2144646
5.

New mechanisms for effects of anti-inflammatory glucocorticoids.

Bailey JM.

Biofactors. 1991 Jun;3(2):97-102. Review.

PMID:
1832865
6.

[Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect].

Bastian BC, Römisch J, Pâques EP, Burg G.

Hautarzt. 1991 Jul;42(7):417-23. Review. German.

PMID:
1834610
7.

Regulation of prostaglandin formation by glucocorticoids and their second messenger, lipocortins.

Hirata F, Stracke ML, Schiffmann E.

J Steroid Biochem. 1987;27(4-6):1053-6. Review.

PMID:
2961939
8.

Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor.

Miele L, Cordella-Miele E, Mukherjee AB.

Endocr Rev. 1987 Nov;8(4):474-90. Review.

PMID:
3319534
9.

Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2.

Davidson FF, Dennis EA.

Biochem Pharmacol. 1989 Nov 1;38(21):3645-51. Review. No abstract available.

PMID:
2532012
10.

Biology of phospholipase inhibitory proteins.

Hirata F, Hirata A.

Adv Exp Med Biol. 1990;279:211-8. Review.

PMID:
2151416
11.

Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.

Miele L, Cordella-Miele E, Facchiano A, Mukherjee AB.

Adv Exp Med Biol. 1990;279:137-60. Review. No abstract available.

PMID:
2151414
12.

Lipocortin.

Flower RJ.

Prog Clin Biol Res. 1990;349:11-25. Review.

PMID:
2144632
13.

Diversity in the lipocortin/calpactin family.

Crompton MR, Moss SE, Crumpton MJ.

Cell. 1988 Oct 7;55(1):1-3. Review. No abstract available.

PMID:
2971450
14.

Topical glucocorticoids and the skin--mechanisms of action: an update.

Ahluwalia A.

Mediators Inflamm. 1998;7(3):183-93. Review.

15.

Lipocortins as antiphospholipase A2 and anti-inflammatory proteins.

Russo-Marie F.

Adv Exp Med Biol. 1990;279:197-210. Review. No abstract available.

PMID:
2151415
16.

Phospholipase A2 as a "death trigger" in the aging process. The use of PLA2 inhibitors as antiaging substances.

Regelson W, Franson R.

Ann N Y Acad Sci. 1991;621:262-76. Review. No abstract available.

PMID:
1859091
17.

Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids?

Parente L, Becherucci C, Perretti M, Solito E, Mugridge KG, Galeotti CL, Raugei G, Melli M, Sanso M.

Prog Clin Biol Res. 1990;349:55-68. Review. No abstract available.

PMID:
2144647

Supplemental Content

Support Center